2605 related articles for article (PubMed ID: 7814155)
1. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts.
Weterman MA; Ajubi N; van Dinter IM; Degen WG; van Muijen GN; Ruitter DJ; Bloemers HP
Int J Cancer; 1995 Jan; 60(1):73-81. PubMed ID: 7814155
[TBL] [Abstract][Full Text] [Related]
2. HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).
Scheibenbogen C; Keilholz U; Mytilineos J; Suciu S; Manasterski M; Hunstein W
Melanoma Res; 1994 Jun; 4(3):191-4. PubMed ID: 7919965
[TBL] [Abstract][Full Text] [Related]
3. Immediate free tissue transfer for distal musculoskeletal neoplasms.
Heiner J; Rao V; Mott W
Ann Plast Surg; 1993 Feb; 30(2):140-6. PubMed ID: 8489178
[TBL] [Abstract][Full Text] [Related]
4. The effect of 5-bromodeoxyuridine on messenger RNA production in cultured cells.
Price PM
Biochim Biophys Acta; 1976 Oct; 447(3):304-11. PubMed ID: 987803
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion.
Dadmarz R; Sgagias MK; Rosenberg SA; Schwartzentruber DJ
Cancer Immunol Immunother; 1995 Jan; 40(1):1-9. PubMed ID: 7828162
[TBL] [Abstract][Full Text] [Related]
6. Sequence specific antisense oligonucleotide analog interference with spermidine/spermine N1-acetyltransferase gene expression.
Fogel-Petrovic M; Vujcic S; Häner R; Regenass U; Mett H; Porter CW
Anticancer Res; 1996; 16(5A):2517-23. PubMed ID: 8917345
[TBL] [Abstract][Full Text] [Related]
7. The use of transformed T cell lines for clonal expansion of human B cells from peripheral blood, spleen, and tumor-infiltrating lymphocytes.
Barbuto JA; Verastegui EL; Hersh EM
Hybridoma; 1993 Feb; 12(1):115-25. PubMed ID: 8454298
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of camptothecin derivatives against human malignant melanoma xenografts.
Pantazis P; Kozielski A; Rodriguez R; Petry E; Wani M; Wall M; Giovanella B
Melanoma Res; 1994 Feb; 4(1):5-10. PubMed ID: 8032218
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.
Simons JW; Mikhak B
Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.
Whitehead RP; Figlin R; Citron ML; Pfile J; Moldawer N; Patel D; Jones G; Levitt D; Zeffren J
J Immunother Emphasis Tumor Immunol; 1993 Feb; 13(2):117-21. PubMed ID: 8318496
[TBL] [Abstract][Full Text] [Related]
11. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated expression of the beta3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice.
Gouon V; Tucker GC; Kraus-Berthier L; Atassi G; Kieffer N
Int J Cancer; 1996 Nov; 68(5):650-62. PubMed ID: 8938149
[TBL] [Abstract][Full Text] [Related]
13. The human early pregnancy factor/chaperonin 10 gene family.
Summers KM; Murphy RM; Webb GC; Peters GB; Morton H; Cassady AI; Cavanagh AC
Biochem Mol Med; 1996 Jun; 58(1):52-8. PubMed ID: 8809346
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of interleukin-2 gene-transfected tumor vaccine in combination with interleukin-6 gene-transfected tumor vaccine].
Cao X; Zhang W; Tao Q
Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):602-5, 639. PubMed ID: 8697075
[TBL] [Abstract][Full Text] [Related]
15. An immunophenotypic survey of malignant melanomas.
Bishop PW; Menasce LP; Yates AJ; Win NA; Banerjee SS
Histopathology; 1993 Aug; 23(2):159-66. PubMed ID: 8406388
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-2 administration on platelet function in cancer patients.
Oleksowicz L; Zuckerman D; Mrowiec Z; Puszkin E; Dutcher JP
Am J Hematol; 1994 Mar; 45(3):224-31. PubMed ID: 8296793
[TBL] [Abstract][Full Text] [Related]
17. Influence of an autocrine diffusible resistance factor on cell survival after exposure to therapeutic agents.
Schlehaider UK; Hill GJ; Hill HZ
Melanoma Res; 1993 Oct; 3(5):357-62. PubMed ID: 8292893
[TBL] [Abstract][Full Text] [Related]
18. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay.
Pötgens AJ; Lubsen NH; van Altena G; Schoenmakers JG; Ruiter DJ; de Waal RM
Thromb Haemost; 1994 Feb; 71(2):208-13. PubMed ID: 8191400
[TBL] [Abstract][Full Text] [Related]
19. Antimetastatic effects of synthetic peptides containing the core sequence of the type III connecting segment domain (IIICS) of fibronectin.
Yamamoto S; Kaneda Y; Okada N; Nakagawa S; Kubo K; Inoue S; Maeda M; Yamashiro Y; Kawasaki K; Mayumi T
Anticancer Drugs; 1994 Aug; 5(4):424-8. PubMed ID: 7949246
[TBL] [Abstract][Full Text] [Related]
20. Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells.
Nakashima M; Janiszewska M; Steplewski Z; Watanabe T; Schuchter L; Koprowski H
Hybridoma; 1994 Jun; 13(3):241-6. PubMed ID: 7927369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
